Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

Gao J, Cahill CM, Huang X, Roffman JL, Lamon-Fava S, Fava M, Mischoulon D, Rogers JT.

Neurotherapeutics. 2018 Jan;15(1):156-175. doi: 10.1007/s13311-017-0593-0.

PMID:
29340929
2.

Assessments of plasma ghrelin levels in the early stages of parkinson's disease.

Song N, Wang W, Jia F, Du X, Xie A, He Q, Shen X, Zhang J, Rogers JT, Xie J, Jiang H.

Mov Disord. 2017 Oct;32(10):1487-1491. doi: 10.1002/mds.27095. Epub 2017 Jul 6.

PMID:
28681931
3.

Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway.

Meng T, Cao Q, Lei P, Bush AI, Xiang Q, Su Z, He X, Rogers JT, Chiu IM, Zhang Q, Huang Y.

Mol Ther Nucleic Acids. 2017 Jun 16;7:439-452. doi: 10.1016/j.omtn.2017.05.004. Epub 2017 May 10.

4.

Morphoproteomic-Guided Treatment of Chemotherapy Resistant Colon Cancer using Natural Based Therapies: A Case Study.

Rogers JT, Brown RE, Buryanek JJ, Weerasinghe P.

Ann Clin Lab Sci. 2017 Mar;47(2):217-220.

PMID:
28442526
5.

Subacute ibuprofen treatment rescues the synaptic and cognitive deficits in advanced-aged mice.

Rogers JT, Liu CC, Zhao N, Wang J, Putzke T, Yang L, Shinohara M, Fryer JD, Kanekiyo T, Bu G.

Neurobiol Aging. 2017 May;53:112-121. doi: 10.1016/j.neurobiolaging.2017.02.001. Epub 2017 Feb 9.

6.

A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity.

Rogers JT, Venkataramani V, Washburn C, Liu Y, Tummala V, Jiang H, Smith A, Cahill CM.

J Neurochem. 2016 Aug;138(3):479-94. doi: 10.1111/jnc.13671.

7.

High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease.

Plascencia-Villa G, Ponce A, Collingwood JF, Arellano-Jiménez MJ, Zhu X, Rogers JT, Betancourt I, José-Yacamán M, Perry G.

Sci Rep. 2016 Apr 28;6:24873. doi: 10.1038/srep24873.

8.

Differential Expression of the Activator Protein 1 Transcription Factor Regulates Interleukin-1ß Induction of Interleukin 6 in the Developing Enterocyte.

Cahill CM, Zhu W, Oziolor E, Yang YJ, Tam B, Rajanala S, Rogers JT, Walker WA.

PLoS One. 2016 Jan 22;11(1):e0145184. doi: 10.1371/journal.pone.0145184. eCollection 2016.

9.

A Novel Closed-Head Model of Mild Traumatic Brain Injury Using Focal Primary Overpressure Blast to the Cranium in Mice.

Guley NH, Rogers JT, Del Mar NA, Deng Y, Islam RM, D'Surney L, Ferrell J, Deng B, Hines-Beard J, Bu W, Ren H, Elberger AJ, Marchetta JG, Rex TS, Honig MG, Reiner A.

J Neurotrauma. 2016 Feb 15;33(4):403-22. doi: 10.1089/neu.2015.3886. Epub 2015 Dec 17.

10.

Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome.

Hethorn WR, Ciarlone SL, Filonova I, Rogers JT, Aguirre D, Ramirez RA, Grieco JC, Peters MM, Gulick D, Anderson AE, L Banko J, Lussier AL, Weeber EJ.

Eur J Neurosci. 2015 May;41(10):1372-80. doi: 10.1111/ejn.12893. Epub 2015 Apr 13.

11.

Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.

Ayton S, Lei P, Hare DJ, Duce JA, George JL, Adlard PA, McLean C, Rogers JT, Cherny RA, Finkelstein DI, Bush AI.

J Neurosci. 2015 Feb 25;35(8):3591-7. doi: 10.1523/JNEUROSCI.3439-14.2015.

12.

Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189.

Reiner A, Heldt SA, Presley CS, Guley NH, Elberger AJ, Deng Y, D'Surney L, Rogers JT, Ferrell J, Bu W, Del Mar N, Honig MG, Gurley SN, Moore BM 2nd.

Int J Mol Sci. 2014 Dec 31;16(1):758-87. doi: 10.3390/ijms16010758.

13.

Triglycerides in the human kidney cortex: relationship with body size.

Bobulescu IA, Lotan Y, Zhang J, Rosenthal TR, Rogers JT, Adams-Huet B, Sakhaee K, Moe OW.

PLoS One. 2014 Aug 29;9(8):e101285. doi: 10.1371/journal.pone.0101285. eCollection 2014.

14.

Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis.

Tao Y, Wang Y, Rogers JT, Wang F.

J Alzheimers Dis. 2014;42(2):679-90. doi: 10.3233/JAD-140396. Review.

PMID:
24916541
15.

Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Shin E, Rogers JT, Devoto P, Björklund A, Carta M.

Exp Neurol. 2014 Jul;257:25-38. doi: 10.1016/j.expneurol.2014.04.011. Epub 2014 Apr 18.

PMID:
24747357
16.

Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.

Bandyopadhyay S, Rogers JT.

Biochem Pharmacol. 2014 Apr 15;88(4):486-94. doi: 10.1016/j.bcp.2014.01.032. Epub 2014 Feb 7. Review.

17.

Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.

Bandyopadhyay S, Cahill C, Balleidier A, Huang C, Lahiri DK, Huang X, Rogers JT.

PLoS One. 2013 Jul 31;8(7):e65978. doi: 10.1371/journal.pone.0065978. Print 2013.

18.

Assessment of gene order computing methods for Alzheimer's disease.

Hu B, Jiang G, Pang C, Wang S, Liu Q, Chen Z, Vanderburg CR, Rogers JT, Deng Y, Huang X.

BMC Med Genomics. 2013;6 Suppl 1:S8. doi: 10.1186/1755-8794-6-S1-S8. Epub 2013 Jan 23.

19.
21.

Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states.

Hahl P, Davis T, Washburn C, Rogers JT, Smith A.

J Neurochem. 2013 Apr;125(1):89-101. doi: 10.1111/jnc.12165. Epub 2013 Feb 25.

22.

Reelin supplementation recovers sensorimotor gating, synaptic plasticity and associative learning deficits in the heterozygous reeler mouse.

Rogers JT, Zhao L, Trotter JH, Rusiana I, Peters MM, Li Q, Donaldson E, Banko JL, Keenoy KE, Rebeck GW, Hoe HS, D'Arcangelo G, Weeber EJ.

J Psychopharmacol. 2013 Apr;27(4):386-95. doi: 10.1177/0269881112463468. Epub 2012 Oct 26.

23.

The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression.

Mikkilineni S, Cantuti-Castelvetri I, Cahill CM, Balliedier A, Greig NH, Rogers JT.

Parkinsons Dis. 2012;2012:142372. doi: 10.1155/2012/142372. Epub 2012 May 29.

24.

The role of phosphoinositide 3-kinase signaling in intestinal inflammation.

Cahill CM, Rogers JT, Walker WA.

J Signal Transduct. 2012;2012:358476. doi: 10.1155/2012/358476. Epub 2012 Apr 9.

25.

Clinical utility of DNA amplification and sequencing to identify a strain of Mycobacterium avium in paraffin-embedded, formalin-fixed biopsies from an immunosuppressed child.

Rogers JT, Procop GW, Steelman CK, Abramowsky CR, Tuohy MT, Shehata BM.

Pediatr Dev Pathol. 2012 Jul-Aug;15(4):315-7. doi: 10.2350/11-07-1061-CR.1. Epub 2012 May 2.

PMID:
22550970
26.

The Drosophila 7SK snRNP and the essential role of dHEXIM in development.

Nguyen D, Krueger BJ, Sedore SC, Brogie JE, Rogers JT, Rajendra TK, Saunders A, Matera AG, Lis JT, Uguen P, Price DH.

Nucleic Acids Res. 2012 Jul;40(12):5283-97. doi: 10.1093/nar/gks191. Epub 2012 Feb 29.

27.

Time-resolved structural evolution of additive-processed bulk heterojunction solar cells.

Rogers JT, Schmidt K, Toney MF, Bazan GC, Kramer EJ.

J Am Chem Soc. 2012 Feb 15;134(6):2884-7. doi: 10.1021/ja2104747. Epub 2012 Feb 1.

PMID:
22276735
28.

Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levels.

Duce JA, Ayton S, Miller AA, Tsatsanis A, Lam LQ, Leone L, Corbin JE, Butzkueven H, Kilpatrick TJ, Rogers JT, Barnham KJ, Finkelstein DI, Bush AI.

Mol Psychiatry. 2013 Feb;18(2):245-54. doi: 10.1038/mp.2011.168. Epub 2012 Jan 3.

PMID:
22212595
29.

CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.

Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA, Weeber EJ, Bickford PC, Gemma C.

J Neurosci. 2011 Nov 9;31(45):16241-50. doi: 10.1523/JNEUROSCI.3667-11.2011.

30.

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

Olivares D, Deshpande VK, Shi Y, Lahiri DK, Greig NH, Rogers JT, Huang X.

Curr Alzheimer Res. 2012 Jul;9(6):746-58. Review.

31.

Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density.

Rogers JT, Rusiana I, Trotter J, Zhao L, Donaldson E, Pak DT, Babus LW, Peters M, Banko JL, Chavis P, Rebeck GW, Hoe HS, Weeber EJ.

Learn Mem. 2011 Aug 18;18(9):558-64. doi: 10.1101/lm.2153511. Print 2011 Sep.

32.

Structural order in bulk heterojunction films prepared with solvent additives.

Rogers JT, Schmidt K, Toney MF, Kramer EJ, Bazan GC.

Adv Mater. 2011 May 24;23(20):2284-8. doi: 10.1002/adma.201003690. Epub 2011 Jan 18. No abstract available.

PMID:
21608040
33.

The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.

Rogers JT, Mikkilineni S, Cantuti-Castelvetri I, Smith DH, Huang X, Bandyopadhyay S, Cahill CM, Maccecchini ML, Lahiri DK, Greig NH.

J Neural Transm (Vienna). 2011 Mar;118(3):493-507. doi: 10.1007/s00702-010-0513-5. Epub 2011 Jan 8.

PMID:
21221670
34.

Secretin deficiency causes impairment in survival of neural progenitor cells in mice.

Jukkola PI, Rogers JT, Kaspar BK, Weeber EJ, Nishijima I.

Hum Mol Genet. 2011 Mar 1;20(5):1000-7. doi: 10.1093/hmg/ddq545. Epub 2010 Dec 15.

PMID:
21159798
35.

Novel drug targets based on metallobiology of Alzheimer's disease.

Bandyopadhyay S, Huang X, Lahiri DK, Rogers JT.

Expert Opin Ther Targets. 2010 Nov;14(11):1177-97. doi: 10.1517/14728222.2010.525352. Review.

PMID:
20942746
36.

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI.

Cell. 2010 Sep 17;142(6):857-67. doi: 10.1016/j.cell.2010.08.014.

37.

Automatic twin statistics from electron backscattered diffraction data.

Marshall PE, Proust G, Rogers JT, McCabe RJ.

J Microsc. 2010 Jun 1;238(3):218-29. doi: 10.1111/j.1365-2818.2009.03343.x.

38.

Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.

Cho HH, Cahill CM, Vanderburg CR, Scherzer CR, Wang B, Huang X, Rogers JT.

J Biol Chem. 2010 Oct 8;285(41):31217-32. doi: 10.1074/jbc.M110.149161. Epub 2010 Jun 17.

39.

A special local clustering algorithm for identifying the genes associated with Alzheimer's disease.

Pang CY, Hu W, Hu BQ, Shi Y, Vanderburg CR, Rogers JT, Huang X.

IEEE Trans Nanobioscience. 2010 Mar;9(1):44-50. doi: 10.1109/TNB.2009.2037745. Epub 2010 Jan 19.

40.

Reelin and apoE actions on signal transduction, synaptic function and memory formation.

Rogers JT, Weeber EJ.

Neuron Glia Biol. 2008 Aug;4(3):259-70. doi: 10.1017/S1740925X09990184. Epub 2009 Aug 13. Review.

PMID:
19674510
41.

The role of T cells in osteoporosis, an update.

Zhao W, Liu Y, Cahill CM, Yang W, Rogers JT, Huang X.

Int J Clin Exp Pathol. 2009 May 20;2(6):544-52.

42.

Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.

Maloney B, Ge YW, Petersen RC, Hardy J, Rogers JT, Pérez-Tur J, Lahiri DK.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):185-201. doi: 10.1002/ajmg.b.30973.

43.

Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

Olivares D, Huang X, Branden L, Greig NH, Rogers JT.

Int J Mol Sci. 2009 Mar;10(3):1226-60. doi: 10.3390/ijms10031226. Epub 2009 Mar 17. Review.

44.

Independent component analysis of Alzheimer's DNA microarray gene expression data.

Kong W, Mou X, Liu Q, Chen Z, Vanderburg CR, Rogers JT, Huang X.

Mol Neurodegener. 2009 Jan 28;4:5. doi: 10.1186/1750-1326-4-5.

45.

Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Cahill CM, Lahiri DK, Huang X, Rogers JT.

Biochim Biophys Acta. 2009 Jul;1790(7):615-28. doi: 10.1016/j.bbagen.2008.12.001. Epub 2008 Dec 29. Review.

46.

Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Patel AK, Rogers JT, Huang X.

Int J Clin Exp Med. 2008;1(2):181-91. Epub 2008 Apr 15.

47.

L-arginine and Alzheimer's disease.

Yi J, Horky LL, Friedlich AL, Shi Y, Rogers JT, Huang X.

Int J Clin Exp Pathol. 2009;2(3):211-38. Epub 2008 Oct 2.

48.

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.

Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ, Huang X, Cahill CM.

Biochem Soc Trans. 2008 Dec;36(Pt 6):1282-7. doi: 10.1042/BST0361282. Review.

49.

A review of independent component analysis application to microarray gene expression data.

Kong W, Vanderburg CR, Gunshin H, Rogers JT, Huang X.

Biotechniques. 2008 Nov;45(5):501-20. doi: 10.2144/000112950. Review.

50.

MicroRNAs can regulate human APP levels.

Patel N, Hoang D, Miller N, Ansaloni S, Huang Q, Rogers JT, Lee JC, Saunders AJ.

Mol Neurodegener. 2008 Aug 6;3:10. doi: 10.1186/1750-1326-3-10.

Supplemental Content

Loading ...
Support Center